<DOC>
	<DOCNO>NCT00244309</DOCNO>
	<brief_summary>The purpose study determine whether drug name tamsulosin ( Flomax ) , another drug name dutasteride ( Avodart ) , combination two drug effective improve urinary symptom decrease rate intermittent self-catheterization prostate brachytherapy .</brief_summary>
	<brief_title>Study Tamsulosin and/or Dutasteride Relieve Urinary Symptoms After Brachytherapy Localized Prostate Cancer</brief_title>
	<detailed_description>Image-guided transperineal permanent prostate brachytherapy ( PI ) accept curative treatment option patient early stage prostate cancer . The severe side effect PI urinary retention require intermittent self-catheterization ( ISC ) . This study assess ability pharmacologic intervention ameliorate post-operative side effect PI . The use tamsulosin dutasteride propose benefit reduce urinary symptom score reduce rate intermittent self-catheterization patient prostate adenocarcinoma prostate implant .</detailed_description>
	<mesh_term>Prostatic Neoplasms</mesh_term>
	<mesh_term>Tamsulosin</mesh_term>
	<mesh_term>Dutasteride</mesh_term>
	<criteria>Patient eligible prostate implant Patient great 18 year age Patient able give inform consent Patient currently take Flomax , Dutasteride Finasteride Patient know hypersensitivity reaction Flomax Dutasteride Patients know hypersensitivity reaction tamsulosin , dutasteride finasteride patient already prior prostate implantation Patients take PDE5 inhibitor include sildenafil ( Viagra ) , tadalafil ( Cialis ) vardenafil ( Levitra ) ineligible participate unless willing discontinue use drug one week prior implant three month implant</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2011</verification_date>
	<keyword>brachytherapy</keyword>
	<keyword>urinary symptom</keyword>
</DOC>